HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spend wisely to eliminate malaria.

Abstract
The countries of the Greater Mekong subregion-Myanmar, Thailand, Laos, Cambodia, and Vietnam-have set a target of eliminating all Plasmodium falciparum malaria by 2025. Generous funding has been provided, principally by The Global Fund to Fight AIDS, Tuberculosis, and Malaria, to achieve this objective and thereby prevent the spread of artemisinin-resistant Plasmodium falciparum to India and Africa. As the remaining time to reach agreed targets is limited and future external funding is uncertain, it is important to be realistic about the future and spend what remaining funding is left, wisely. New, labour intensive, vertical approaches to malaria elimination (such as the 1-3-7 approach) should not be promoted as these are unproven, likely to be ineffective, costly, and unlikely to be sustainable in the most remote areas where malaria prevalence is highest. Instead, the focus should be on reducing the malaria burden more rapidly in the remaining localised high transmission foci with proven effective interventions, including mass drug administration. Well supported community-based health workers are the key operatives in controlling malaria, but their remit should be broadened to sustain the uptake of their services as malaria declines. This strategy is a sustainable evolution, which will improve rural health care while ensuring progress towards malaria elimination.
AuthorsFrank M Smithuis, Nicholas J White
JournalThe Lancet. Infectious diseases (Lancet Infect Dis) Vol. 22 Issue 6 Pg. e171-e175 (06 2022) ISSN: 1474-4457 [Electronic] United States
PMID34953537 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022 Elsevier Ltd. All rights reserved.
Chemical References
  • Antimalarials
Topics
  • Antimalarials (pharmacology, therapeutic use)
  • Humans
  • Malaria (drug therapy, epidemiology, prevention & control)
  • Malaria, Falciparum (drug therapy, epidemiology, prevention & control)
  • Mass Drug Administration
  • Plasmodium falciparum

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: